Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edesa Biotech, Inc. - Common Shares (NQ:EDSA)

2.710 +0.290 (+11.98%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 73,384
Open 2.450
Bid (Size) 2.540 (2)
Ask (Size) 2.900 (10)
Prev. Close 2.420
Today's Range 2.430 - 2.744
52wk Range 1.550 - 4.490
Shares Outstanding 3,467,658
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Edesa Biotech Posts Narrower Loss in Q3
Via The Motley Fool

Performance

YTD
+42.2%
+42.2%
1 Month
+10.6%
+10.6%
3 Month
+12.5%
+12.5%
6 Month
+13.9%
+13.9%
1 Year
-29.1%
-29.1%

More News

Read More
Wondering what's happening in today's pre-market session?
Via Chartmill
Dow Jumps Over 100 Points; Deere Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Nasdaq Surges 150 Points; Cisco Earnings Top Views
Via Benzinga
US Stocks Edge Higher; Producer Prices Increase In January
Via Benzinga
Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
EDSA Stock Earnings: Edesa Biotech Beats EPS for Q3 2024
Via InvestorPlace
BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS
Via ACCESSWIRE
EDSA Stock Earnings: Edesa Biotech Beats EPS for Q2 2024
Via InvestorPlace
Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
Via ACCESSWIRE
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
Via ACCESSWIRE
Edesa Biotech to Participate in Upcoming Investor Conferences
Via ACCESSWIRE
Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference
Via ACCESSWIRE
Edesa Biotech to Participate in Barclays Global Healthcare Conference
Via ACCESSWIRE
Edesa Biotech to Participate in Upcoming Dermatology Meetings
Via ACCESSWIRE
Edesa Biotech Reports Fiscal 1st Quarter 2024 Results
Via ACCESSWIRE
Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week
Via ACCESSWIRE
EDSA Stock Earnings: Edesa Biotech Beats EPS for Q4 2023
Via InvestorPlace
Edesa Biotech Reports Fiscal Year 2023 Results
Via ACCESSWIRE
Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study
Via ACCESSWIRE

Frequently Asked Questions

Is Edesa Biotech, Inc. - Common Shares publicly traded?
Yes, Edesa Biotech, Inc. - Common Shares is publicly traded.
What exchange does Edesa Biotech, Inc. - Common Shares trade on?
Edesa Biotech, Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Edesa Biotech, Inc. - Common Shares?
The ticker symbol for Edesa Biotech, Inc. - Common Shares is EDSA on the Nasdaq Stock Market
What is the current price of Edesa Biotech, Inc. - Common Shares?
The current price of Edesa Biotech, Inc. - Common Shares is 2.710
When was Edesa Biotech, Inc. - Common Shares last traded?
The last trade of Edesa Biotech, Inc. - Common Shares was at 10/21/25 03:59 PM ET
What is the market capitalization of Edesa Biotech, Inc. - Common Shares?
The market capitalization of Edesa Biotech, Inc. - Common Shares is 9.40M
How many shares of Edesa Biotech, Inc. - Common Shares are outstanding?
Edesa Biotech, Inc. - Common Shares has 9M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.